SHARE

Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals
01.07.2024

Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals

Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals

On June 14, 2024, Dr. Francesco Fontana (R&D Director), Dr. Dario Telese (Lead Chemist), and Dr. Lucija Ptiček (Synthesis Laboratory Specialist) from the Porton Slovenian site presented a lecture on the Master PRO-API program of the University of Perugia. The lecture, titled "Introduction to the Green Chemistry Metrics – Innovation Green Aspiration Level (iGAL)," The post-graduate master training program designed to prepare young graduates and post-graduates for careers as Process Chemists in the pharmaceutical industry. This program aims to provide participants with both methodological foundations and advanced specialist skills necessary for developing processes for producing active ingredients and pharmaceutical intermediates. It combines multidisciplinary theoretical instruction with practical experience gained through extended internships at industry-related companies. The ultimate goal is to equip participants with a comprehensive understanding of the terminology, principles, and methods essential for process development and the production of pharmaceutical intermediates and active ingredients.

Porton's new R&D facility in Slovenia spans approximately 1,000 square meters and includes four API process labs, six analytical labs, and a kilo-lab built to OEB 4 (≥1µg/m³) standards. The facility is capable of operating under both non-GMP and GMP conditions. The labs are equipped to handle a wide array of reactions and processes, such as enzymatic reactions, metal catalysis, pressure reactions (including hydrogenation and carbonylation, etc.), and cryogenic - high-temperature reactions (ranging from -80°C to 200°C). This enables the facility to provide R&D services for API projects across various clinical stages. To date, the Porton Slovenia site has hired over 30 new employees and has initiated construction of a pilot plant. Once completed, this pilot plant will enable Porton to supply well-known international pharmaceutical companies with the first batches of APIs.

The Porton team is proud to contribute to the training and development of the new generation of Process Chemists, with a focus on the increasingly important Process Sustainability Metrics. Porton applies these metrics as a standard practice in its projects, not just during Process Development but throughout the entire products lifecycle. We hope that Master PRO-API students will integrate these lessons into their Process Chemist Toolbox!

Master of PRO-API (Process Development for the Production of Active Pharmaceutical Ingredients)

An advanced training program offered by the Department of Pharmaceutical Sciences at the University of Perugia, initiated by Professor Maura Marinozzi. As the first master's program in Italy of its kind, it provides an all-encompassing overview of activities related to the development and production of APIs, with a strong focus on chemistry. The program collaborates with Federchimica-Aschimfarma under a specific agreement, the PRO-API master's degree lasts one year and is divided into a semester of frontal teaching and a semester of full-time internship in the company.  visit: https://masterproapi.it/

About Porton PharmaTech D.O.O. (Porton Slovenia)

Porton PharmaTech D.O.O. serves as the European subsidiary of Porton Pharma Solutions Ltd. It stands as the first CDMO (Contract Development and Manufacturing Organization) in the pharmaceutical industry in Slovenia, offering comprehensive services that include synthesis route development, process familiarization, analytical methods development, and validation, as well as process scale-up. At Porton PharmaTech, d.o.o, Customers are fully supported by an integrated project team committed to deliver services and products within expected timelines and quality.

About Porton Pharma Solutions Ltd.

Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for Small Molecules, TIDES, Biologics, ADCs from pre-clinical to commercial. As of December 31, 2023, we have a proven record for the delivery of more than 3000 projects and established cooperation with more than 1000 global clients.

SHARE

Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals
Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details